Status:

COMPLETED

Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy

Lead Sponsor:

University Hospital, Geneva

Collaborating Sponsors:

Geneva University, School of medicine

Conditions:

Parathyroid Function Low Adverse Event

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Evaluate parathyroid gland perfusion during total thyroidectomy or thyroid totalisation surgery. Create an objective basis for the decision whether or not to transplant the parathyroid glands. Avoide ...

Detailed Description

Parathyroid intraoperative indocyanine green (ICG) angiography is a new concept. To simplify the procedure the investigators have classified images into three categories: ICG 2: good blood supply (the...

Eligibility Criteria

Inclusion

  • Adult patients undergoing total thyroidectomy or a totalisation thyroid procedure.
  • Patients capable of understanding and able to understand the study.
  • Values visually 2 and ICG 2

Exclusion

  • Parathyroid disease or prior parathyroidectomy
  • Lack of informed consent
  • Altered mental status of the patient.
  • ICG values \<2.

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2016

Estimated Enrollment :

146 Patients enrolled

Trial Details

Trial ID

NCT02249780

Start Date

September 1 2014

End Date

February 1 2016

Last Update

April 18 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals Geneva

Geneva, Canton of Geneva, Switzerland, 1205

Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy | DecenTrialz